E-LIB Suche - Ergebnisse für: I. A. Pokataev

1

227P The role of CDK4/6 inhibitors in sequencing of endocri..:

Stativko, O. ; Tsareva, E. ; Khachaturian, E....
ESMO Open. 9 (2024) - p. 103249 , 2024

2

Gut Microbiome as a Predictor of the Anti-PD-1 Therapy Succ..:

Fedorov, D. E. ; Pavlenko, A. V. ; Olekhnovich, E. I....
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 15 (2021) 2 - p. 161-165 , 2021

Link: https://doi.org/10.1134/..

3

Meta-analysis of the studies dedicated to the predictive si..:

Popova, A. S. ; Fedyanin, M. Yu. ; Pokataev, I. A..
Journal of Modern Oncology. 22 (2020) 3 - p. 127-132 , 2020

Link: https://doi.org/10.26442..

4

502 POSTER Modification of cisplatin administration schedul..:

Bogush, T.A. ; Polotskiy, B.E. ; Bogush, E.A....
European Journal of Cancer Supplements. 6 (2008) 12 - p. 159-160 , 2008

Link: https://doi.org/10.1016/..

5

Experimental method for testing the precision of strobotach..:

Pokataev, A. I.
Measurement Techniques. 10 (1967) 7 - p. 878-879 , 1967

Link: https://doi.org/10.1007/..

6

Advisory board resolution: The role of the adjuvant atezoli..:

V. V. Breder ; I. A. Pokataev ; V. V. Petkau...
https://www.med-sovet.pro/jour/article/view/7980/7067. , 2024

Link: https://www.med-sovet.pr..

7

Systemic therapy for metastatic pancreatic cancer ; Лекарст..:

Y. E. Chikhareva ; M. Yu. Fedyanin ; I. S. Bazin...
https://www.malignanttumors.org/jour/article/view/1157/804. , 2023

Link: https://www.malignanttum..

8

Preoperative chemotherapy usage experience for intrahepatic..:

A. N. Polyakov ; D. A. Granov ; Yu. I. Patyutko...
https://www.rpmj.ru/rpmj/article/view/860/538. , 2023

Link: https://www.rpmj.ru/rpmj..

9

Effcacy and toxicity of regorafenib compared to reintrodact..:

E. S. Kuzmina ; M. Yu. Fedyanin ; I. V. Reshetov...
https://www.siboncoj.ru/jour/article/view/2675/1135. , 2023

Link: https://www.siboncoj.ru/..

10

Russian consensus on prevention, diagnosis and treatment of..:

I. E. Khatkov ; S. R. Abdulkhakov ; S. A. Alekseenko...
https://www.malignanttumors.org/jour/article/view/1091/787. , 2023

Link: https://www.malignanttum..

11

Olaparib maintenance therapy after frontline chemotherapy i..:

A. A. Rumyantsev ; A. S. Tyulyandina ; I. A. Pokataev...
https://www.med-sovet.pro/jour/article/view/6919. , 2022

Link: https://doi.org/10.21518..

12

Interdisciplinary approach to the management of patients wi..:

K. Yu. Morkhov ; Yu. M. Kreinina ; I. A. Pokataev.
https://ojrs.abvpress.ru/ojrs/article/view/937. , 2022

Link: https://doi.org/10.17650..

13

Olaparib maintenance therapy after frontline chemotherapy i..:

A. A. Rumyantsev ; A. S. Tyulyandina ; I. A. Pokataev...
https://www.med-sovet.pro/jour/article/view/6919/6217. , 2022

Link: https://www.med-sovet.pr..

14

Efficacy of non‑platinum chemotherapy in platinum‑resistant..:

A. Rumyantsev A ; A. Tyulyandina S ; E. Israelyan R...
https://www.malignanttumors.org/jour/article/view/942/673. , 2022

Link: https://www.malignanttum..

15

Unresectable hepatocellular carcinoma: prospects for drug t..:

V. Breder V ; D. Abdurakhmanov T ; V. Petkau V...
https://www.malignanttumors.org/jour/article/view/919/665. , 2022

Link: https://www.malignanttum..